SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-019231
Filing Date
2020-02-12
Accepted
2020-02-12 16:10:36
Documents
3
Period of Report
2020-02-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm207781d1_8k.htm 8-K 18596
2 EXHIBIT 99.1 tm207781d1_ex99-1.htm EX-99.1 66935
3 GRAPHIC logo.jpg GRAPHIC 21397
  Complete submission text file 0001104659-20-019231.txt   116359
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10113 | Film No.: 20604162
SIC: 2834 Pharmaceutical Preparations